CompletedPhase 4NCT01831050

Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fidec Corporation
Principal Investigator
Edwin J Asturias, MD
University of Colorado, Denver
Intervention
Bivalent Oral Polio Vaccine (bOPV)(biological)
Enrollment
1420 target
Eligibility
All sexes
Timeline
20132014

Study locations (4)

Collaborators

Bill and Melinda Gates Foundation · Centers for Disease Control and Prevention

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01831050 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials